logo
Select company
Select metric
$ 438KCapital Expenditure
VS
Market
74
Sector
51
Industry
36
History
64
$ 0.76Close
$ 0.65 - $ 1.48 52-Week Range
Ticker Information

Ticker

XLO

Company Name

XILIO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XILIO THERAPEUTICS INC - Capital Expenditure Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XLO - CapEx Historical data
DateCapital Expenditure
6/30/2025$ 438K
3/31/2025$ 58K
12/31/2024$ 36K
9/30/2024$ 30K
6/30/2024$ 21K
3/31/2024$ 316K
12/31/2023$ 486K
9/30/2023$ 995K
6/30/2023$ 1.33M
3/31/2023$ 1.78M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XILIO THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx stands at $ 2.19M.
  • Over the past 5 years, XILIO THERAPEUTICS INC's average CapEx has been $ 926.6K.
  • The median CapEx for XILIO THERAPEUTICS INC during this period was $ 995K
  • XILIO THERAPEUTICS INC reached its highest CapEx over the past 5 years at $ 2.19M.
  • The lowest CapEx recorded by XILIO THERAPEUTICS INC in the same timeframe $ 21K

XILIO THERAPEUTICS INC's CapEx vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Benchmarks
CompanyCapEx
BRNS : BARINTHUS BIOTHERAPEUTICS PLC $ 429KBCAB : BIOATLA INC $ 0GBIO : GENERATION BIO CO $ 848KCRIS : CURIS INC $ 0EQ : EQUILLIUM INC $ 8KVVOS : VIVOS THERAPEUTICS INC $ 1.25MVRCA : VERRICA PHARMACEUTICALS INC $ 8KVERU : VERU INC $ 64.12KIRD : OPUS GENETICS INC $ 0NEPH : NEPHROS INC $ 0

Definition of Capital Expenditure

[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.

XLO - Capital Expenditure, Last 5 years

$ 21K

Minimum

Jun 30, 2024

$ 2.19M

Maximum

Dec 31, 2020

$ 926.6K

Average

$ 995K

Median

CapEx Benchmark Analysis

The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.66M with a standard deviation of $ 15.86M.
The following table provides additional summary stats:
CapEx in the Market:
filtered constituents2.92K
min$ -41.06M
max$ 63.78M
average$ 9.66M
median$ 1.92M
std$ 15.86M